Kids Back to School? Our Tech can Help Ease Your Mind.

With BinaxNOW COVID-19 rapid tests and connected diabetes care, feel better about the return to classrooms.

As the COVID-19 pandemic kept many kids out of the classroom for more than a year-and-a-half, students around the country are venturing from their rooms at home to First Period home room to rejoin classmates.

And parents understandably could be feeling the anxiety of separation.

How to cut that uncertainty? Preparation.

We know that just because they'll be out of sight doesn't mean they'll be out of mind. Our technologies to help ease your mental load and provide more control to parents heading into the school year.

With the Delta variant of COVID-19 dominating — a strain that's demonstrating it's highly transmissible, more so than even the common cold, chicken pox or the flu — BinaxNOW rapid antigen testing can quickly and reliably let parents know their children's COVID status before they return to the classroom.

And for parents and caregivers of children over 4 using the FreeStyle Libre 2 continuous glucose monitoring system to manage their diabetes, apps including the FreeStyle Libre 2 iOS app and Libre LinkUp1 app can share data collected by the FreeStyle Libre 2 sensor so you can see how your child's glucose levels are doing during the school day.

Children returning to classrooms can feel like the new "distance learning," with an uncomfortable emphasis on the distance between parents and kids. We want to help restore your confidence as they step through the schoolhouse door.

Our technologies are designed to be accessible and affordable to help alleviate those worries so you have time for more pressing concerns, from their grades and college entrance exams to making the team and being cast in the school play.

1The LibreLinkUp app is only compatible with certain mobile device and operating systems. Please check for more information about device compatibility before using the app.

This story was originally published on August 27, 2021 and updated on June 13, 2022.




Failure to use FreeStyle Libre 2 system as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If glucose alarms and readings do not match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Seek medical attention when appropriate or contact Abbott at 855-632-8658 or for safety info.


The BinaxNOW™ COVID-19 tests have not been FDA cleared or approved. They have been authorized by the FDA under an emergency use authorization. They have been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens, and are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner. For serial testing, the BinaxNOW COVID-19 Antigen Tests should be performed twice over 3 days, at least 24 hours (and no more than 48 hours) apart. For symptomatic use, a single test can be used.